Catalina Soare Email

VP Preclinical Translational Development . SciVac Limited

Current Roles

Employees:
59
Revenue:
$9.1M
About
SciVac Ltd., a subsidiary of VBI Vaccines Inc. (Nasdaq: VBIV), has the facilities and expertise that enable development of therapeutic proteins starting with a selected clone, through production, purification, and analytical testing. For your phase I and II clinical trials, SciVac Ltd. offers manufacturing services under cGMP conditions.
SciVac Limited Address
Gad Feinstein Rd.
Rehovot, null
ISR
SciVac Limited Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.